AFRIN No Drip Severe Congestion Recalled for Improper Storage Temperature
Family Dollar Stores is recalling AFRIN No Drip Severe Congestion 0.5 FL oz due to improper storage temperature conditions (CGMP deviation). The product was distributed to specific Family Dollar locations from April 30 through June 10, 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II drug recall involving a current good manufacturing practice (CGMP) deviation for improper storage temperature conditions. The source material contains no reports of illnesses or injuries, placing it at the maximum score permitted for recalls without reported harm.
Plain-English summary
Family Dollar Stores, LLC is recalling AFRIN No Drip Severe Congestion 0.5 FL oz (SKU 902045) distributed to specific Family Dollar store locations nationwide from April 30 through June 10, 2022.
The recalled product was held outside appropriate storage temperature conditions during distribution, constituting a current good manufacturing practice (CGMP) deviation. Improper storage conditions can affect pharmaceutical product stability and safety.
The recall affects consumers who purchased this product from affected Family Dollar locations during the specified dates.
Consumers who have purchased this product are advised to discontinue use. For questions or to arrange return of the product, contact Family Dollar Stores.
The recalled product
- Product
- AFRIN NO DRIP SEVERE CONGESTION 0.5FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Nasal Decongestant
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902045
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27